News and Events Archive

Posts in Whitepapers

New White Paper: The Microbiome and Immuno-Oncology

Blog, Jonathan Barry Posts, Peter Bak Posts, WhitepapersBack Bay Life Science AdvisorsFebruary 25, 2019cancer treatment, Drug development, immuno-oncology, microbiome

New White Paper: A Rare-Disease Approach to Seizure Treatment

Michelle Hoffmann Posts, Susan Thompson Posts, WhitepapersBack Bay Life Science AdvisorsDecember 18, 2018Biotech, Drug development, Epilepsy, Rare diseases, Seizure

Effective Strategy and Partnering Approaches For University-Generated IP

News, Whitepapers, Jonathan GertlerBack Bay Life Science AdvisorsOctober 17, 2018Tech Transger, Academic-Industry Partnering

Neoantigen-Based Cancer Immunotherapy: One Step Closer to the Promise of Personalized Medicine

WhitepapersPeter Bak, PhDJune 3, 2018ASCO, Cancer, Check Point Inhibitors, immuno-oncology, Neoantigens, Oncology

Back Bay Report on Neoantigen-Based Cancer Immunotherapy

Blog, Jonathan Gertler Posts, Michelle Hoffmann Posts, Peter Bak Posts, WhitepapersBack Bay Life Science AdvisorsJune 3, 2018ASCO, Cancer, CART-T, immuno-oncology, Neoantigens, Oncology, T Cell, White Paper

Transcatheter Mitral Valve Technologies: The Heart of Cardiovascular Device Innovation

News, WhitepapersBack Bay Life Science AdvisorsMay 16, 2018Cardiovascular Technology, healthcare, White Paper

White Paper: US Biosimilars 2018: Opportunities and Challenges

News, WhitepapersBack Bay Life Science AdvisorsJanuary 3, 2018Biotech, healthcare, Jonathan Gertler, Wall Street Journal, WSJ